OSR HEALTH, INC. Cash
OSR HEALTH, INC. (OSRH) had Cash of $66.14 thousand as of 2024-12-31, per its 10-K filed 2025-04-22.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-04-22
- 2024-12-31: Cash $66.14K.
- 2024-09-30: Cash $12.24K.
- 2024-06-30: Cash $119.12K.
- 2024-03-31: Cash $3.64K.
| Period end | Cash |
|---|---|
| 2024-12-31 | $66.14K 10-K · filed 2025-04-22 |
| 2024-09-30 | $12.24K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $119.12K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $3.64K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $15.42K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $57.95K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.18K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $348.80K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $124.50K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |